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Agonistic anti.Fas antibodies induce glomerular cell apoptosis in mice
in vivo. Recent studies suggest that apoptotic cell death regulates the cell
complement in glomerular diseases. However, little is known about the
factors that promote glomerular cell apoptosis. Activation of the Fas
receptor by the Fas ligand or agonistic antibodies triggers apoptosis in
some cell types that express Fas. Cultured human mesangial cell are
among the cells that undergo apoptosis upon Fas activation, but it is
unclear whether mesangial cells are sensitive to death induced by Fas in
vivo. We have now explored the role of Fas in experimental glomerular
injury. Murine mesangial cells in culture express fas and undergo apopto-
sis when stimulated with the Jo2 agonistic anti-Fas mAb. A fas mRNA
transcript is present in normal murine kidney and freshly isolated glomer-
uli. Balb-c mice developed hematuria and proteinuria within 24 hours of
the intraperitoneal injection of 10 g Jo2 anti-Fas mAb. In addition to
liver cell apoptosis, glomerular cell apoptosis and mesangial cell depletion
were evident in the kidney at three hours and more pronounced at 24
hours. Glomerular and liver injury were not prevented by decomplemen-
tation. These data suggest that Fas activation in viva by specific antibodies
induces glomerular and mesangial cell apoptosis in mice.
Abnormalities of cell number are a frequent feature of glomer-
ular disorders [1]. Mesangial hypercellularity is present in prolif-
erative glomerulonephritis, and mesangial cell depletion charac-
terizes glomerular atrophy of chronic renal disease. Homeostasis
of cell number is the outcome of the coordination of cell birth
(mitosis) and cell death [21. Physiological cell death usually takes
place by apoptosis [21. Occasionally other processes, such as cell
migration and cell differentiation, are also involved in the regu-
lation of cell number [3]. Several cytokines have been shown to
promote mesangial cell proliferation and survival [4—7]. Much less
is known about the regulation of mesangial cell death.
Apoptosis is an active form of cell death that is characterized by
a typical morphology and by functional features such as internu-
cleosomal DNA degradation [1]. Apoptosis is tightly regulated by
extracellular and intracellular factors [8—10]. Factors that trigger
apoptosis, effectors of apoptosis and protective factors have been
identified in invertebrates and vertebrates [8—10]. Several triggers
of apoptosis share a death domain present in the Drosophila death
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factor, Reaper [8]. Both the 55 kDa tumor necrosis factor (TNF)
receptor and the Fas receptor possess this domain [8]. TNF is one
of a handful of cytokines that fulfills a set of criteria that
implicates them in the pathogenesis of glomerular injury [11].
These criteria include the ability to elicit biological responses in
cultured glomerular cells and the capacity to induce or increase
glomerular damage when administered to experimental animals
[reviewed in 11]. The Fas ligand is a TNF-like cytokine expressed
by T lymphocytes, that mediates T cell cytotoxicity [12—14]. The
Fas ligand binds to the Fas receptor, which shares homology with
the extracellular portion of TNF receptors [15]. Activation of Fas
by either its natural ligand or agonistic anti-Fas mAb results in the
apoptotic death of some, but not all, the cell types that express Fas
[12, 16—271. Sensitivity to Fas-induced death depends not only on
the surface expression of the Fas receptor, but also on the
presence of soluble Fas receptors [28], the expression of lethal
factors such as interleukin-1-converting enzyme (ICE) and Fas-
associated death domain (FADD) [21, 22] and the expression of
protective factors such as Bel-xL, Bcl-2, Bag-i and Fas-associated
phosphatase-1 (FAP-1) [23—271. When the expression of these
factors is permissive for survival, Fas activation may result in cell
proliferation instead of cell death [25]. As both T cell infiltration
[29] and apoptosis [6, 30] have been described in the course of
glomerular injury, Fas is a candidate mediator of glomerular cell
death. We have previously shown that cultured human mesangial
cells express Fas receptor and undergo apoptosis upon Fas
activation [31]. However, this does not necessarily imply that
mesangial cells are sensitive to Fas-induced death in vivo, when
immersed in their physiological milieu. We have now studied the
ability of agonistic anti-murine Fas mAb to induce mesangial cell
damage in vivo.
Methods
Cells and antibodies
Both the murine mesangial MMC cell line (from SJL mice; a
kind gift from Eric G. Neilson, University of Pennsylvania,
Pittsburgh, PA, USA) [32], and primary cultures of murine
mesangial cells in the 4 to 10th passages (from SJL and MRL+I+
mice; a kind gift from B. Cizman, University of Pennsylvania, and
from Balb c mice) were studied. Cells were cultured in RPMI 1640
(GIBCO, Grand Island, NY, USA) 10% decomplemented FCS, 2
mM glutamine, 100 j.t/ml penicillin and 100 rg/ml streptomycin, at
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37°C in 5% CO2 [32]. Cells were rested in 0.5% FCS RPMI for 24
hours prior to cell death studies.
The Jo2 anti-murine Fas mAb activates the murine Fas recep-
tor [191. Jo2 (a hamster IgG) and control hamster IgG were
obtained from Pharmingen (San Diego, CA, USA). The endo-
toxin contamination was < 0.005 ng/.Lg protein.
Studies of cell death
For morphological assessment of apoptosis cells were grown in
8-well Labtek glass slides (Nunc mc, Napersville, IL, USA) and
stimulated with either an anti-Fas mAb or an irrelevant control
IgG for 24 hours. They were then washed with PBS, fixed with
10% buffered formalin, washed, and stained in 10 j.tg/ml pro-
pidium iodide, 100 /Lgjml RNAse A, PBS pH 7.2, at 37°C for 30
minutes. Preparations were mounted in 90% glycerol/PBS and
examined under a fluorescence microscope. The percentage of
cells with apoptotic nuclei (dense, shrunk, fragmented) was
calculated by an observer (who was blinded to the source of the
cells) in at least 1000 cells per sample [31]. For electron micros-
copy, cells were fixed in 4% paraformaldehyde, 0.05% glutaralde-
hyde in PBS pH 7.2 for two hours and then processed as
previously described [33].
To study the presence of DNA fragmentation, cells were lysed
in 0.1% Triton X-100, 10 mi EDTA, 50 mrvt Tris at 4°C for 10
minutes. After centrifugation, low molecular weight DNA from
the supernatant was extracted, precipitated, digested with 10
sg/ml RNAse A at 37°C for 30 minutes, separated in a 1.5%
agarose gel and stained with ethidium bromide.
Cell DNA content was assessed by flow cytometry. Cells
cultured in 12-well plates were resuspended in 100 pg/mI pro-
pidium iodide, 10 sg/ml RNAse A, 0.05% NP-40, in PBS; the
mixture was incubated at 4°C for one hour and then analyzed on
the FACScan using LYSIS II software [31]. Cells with decreased
DNA content (A0) were considered apoptotic.
Animals and experimental design
Female 4-week-old Balb/c mice (IFFA-CREDO, Barcelona,
Spain) were injected i.p. with 10 .tg Jo2 agonistic anti-Fas mAb
(N = 22) [19], 10 g control hamster IgG (N = 3), vehicle (100 pJ
sterile 0.9% NaCI; N = 2) or non-injected (N = 4). Animals were
sacrificed at different time points after the injection of anti-Fas
mAb. Organs were perfused with cold 0.9% NaCI. Tissue samples
were processed for histological studies, and snap-frozen in liquid
nitrogen for isolation of DNA and RNA. The presence of DNA
fragmentation was investigated in tissues lysed in 100 mivi NaC1, 10
mM Tris, 25 mrvi EDTA, 1% SDS, 200 jsg/ml proteinase K in PBS,
pH 7.2 at 37°C for 18 hours.
Some mice were decomplemented before the injection of
anti-Fas mAb (N = 3) or control hamster IgG (N = 3). Three
injections of 125 U/kg cobra venom factor from Naja naja
kaouthia (Sigma, St Louis, MO, USA) were administered i.p. at
eight hour intervals before anti-Fas injection, following previously
established protocols [34, 35]. Double immunodiffusion confirmed
serum depletion of C3 to < 5% of controls. This level of C3
depletion has previously been shown to prevent complement-
dependent mesangial cell lysis [36].
Proteinuria and hematuria were assessed by dipstick (Combur
Test; Boehringer Mannheim, Mannheim, Germany).
Histological studies
Tissue was fixed in 10% buffered formalin and embedded in
paraffin. Sections 2 to 3 xm thick were stained with hematoxylin-
eosine, Masson trichrome and PAS. The degree of tissue damage
was assessed semiquantitatively by two independent pathologists
who were blinded to the source of the tissue. Cells were consid-
ered apoptotic when nuclei were pyknotic and fragmented. Liver
cell apoptosis was scored and defined as: 0 = absence; 1 + =
25% apoptotic cells; 2+ = 25 to 50% apoptotic cells; 3+ = >
50% apoptotic cells. Mesangial cell apoptosis was scored and
defined as: 0 = absence; 1 + = apoptotic cells in < 50% of
glomeruli; 2+ = apoptotic cells present in > 50% of glomeruli.
Mesangiolysis was defined as the presence of acellular mesangial
matrix. It was scored as: 0 = absence; I + = mild; 2+ = severe.
The number of apoptotic cells was counted in 40 glomerular
cross sections by oil-immersion light microscopy of PAS-stained
sections. The counts obtained with these method closely correlate
with those done either by propidium iodide staining or TdT
labeling [6, 30].
Tissue sections were also stained with propidium iodide as
detailed above, with the additional step of treating for 30 minutes
with 20 g/ml proteinase K before staining.
DNA fragmentation was detected in situ by the method of
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick
end labeling (TUNEL), using a commercial kit (Apoptag, Oncor,
Gaithersburg, MD, USA) and following the manufacturer's in-
structions. This method is based upon the activity of TdT to
catalyze the incorporation of digoxigenin-dUTP into 3-OH ends
of fragmented DNA, and subsequent detection of the incorpo-
rated dUTP with specific antibodies.
For immunofluorescence kidney tissue was embedded in OCT
and snap frozen in liquid nitrogen [371 Sections were fixed in cold
methanol/acetone for 10 minutes, washed with PBS and blocked
with 10% FCS in PBS for 30 minutes. For assessment of glomer-
ular C3 deposits, samples were incubated in a 1:100 dilution of
FITC anti-murine C3 (Cappel, West Chester, PA, USA) in 0.2%
BSA/PBS at room temperature for 30 minutes. Positive controls
were kidneys from mice with anti-GBM ncphritis.
Northern hybridization
Glomeruli isolated by a differential sieving technique from four
healthy mice were pooled [32]. Total RNA was isolated from cells
and organs using the acid-guanidine-phenol-chloroform method
[38] and 25 jxg were separated in 1% agarose gels containing 2.3%
formaldehyde. RNA was transferred to nylon membranes (Gene-
screen; NEN, Boston, MA, USA) and pre-hybridized and hybrid-
ized as previously described [37].
The Fas probe is a PCR product obtained from murine eDNA
by the use of the following primers: Fas 556 5' sense, CGC CTA
TOG ITO TFG ACC; Fas 1033 3'antisense, CTC CAG ACA
TTG TCC TFC [39, 40]. The probe has been cloned and
sequenced to confirm its identity.
Statistics
Results are expressed as mean SEM. Significance at the 95%
level was established using ANOVA and Student's t-test.
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Fig. 1. Cultured murine mesangial cells express fas mRN.4 and a functional
Fas receptor. A. Northern blot. Afas transcript was detected in 25 xg total
RNA obtained from the MMC murine mesangial cell line, primary
cultures of mesangial cells (Mes), healthy mouse kidney and freshly
isolated glomeruli form healthy mice. B. Fas activation induces apoptosis
of murine mcsangial cells in culture. Cells were exposed to control
hamster IgG (10 j.rglml) or agonistic anti-Fas mAb for 24 hours. The
percentage of nuclei with apoptotic morphology was counted in at least
1000 cells stained with propidium iodide after formalin fixation. Results
are expressed as mean SCM. < 0.002 versus control IgG.
Results
Agonistic anti-Fas mAb induce apoptosis of cultured murine
mesangial cells
Northern blot hybridization showed that primary cultures of
murine mesangial cells, the MMC cell line, murine kidneys and
freshly isolated murine glomeruli express an approximately 2 kh
transcript of the fas gene (Fig. 1A), similar to that present in liver
(not shown). In cultured mesangial cells, activation of the Fas
receptor by anti-Fas mAb increased, in a dose-dependent manner,
the percentage of cells with apoptotic morphology, as assessed by
propidium iodide staining (10 jig/mI anti-Fas 28 1.6% cells with
apoptotic nuclei at 24 hr, vs. 10 tg/ml lgG 0.05 0.02%; P <
0.002; Fig. 1B). Apoptotic nuclei were condensed and fragmented,
in contrast to the bigger, pale nuclei of healthy cells (Fig. 2 A, B).
Electron microscopy disclosed chromatin condensation and nu-
clear fragmentation (Fig. 2C). The percentage of cells with
decreased DNA content (A0), another feature of apoptosis, was
increased by anti-Fas mAb (Fig. 2D). Low molecular weight DNA
isolated from anti-Fas-treated cells displayed internucleosomal
DNA fragmentation (Fig. 2E).
Agonistic anti-Fas mAb induce mesangial cell injury in vivo
We then tested the ability of the anti-Fas mAb to induce
mesangial cell injury in vivo. Mortality among mice injected with
anti-Fas was 30% at 24 hours (3 out of 9). No deaths were
observed in the first 12 hours. Proteinuria and hematuria were
detected at 6, 10 and 24 hours after anti-Fas injection (Table 1).
Glomerular damage developed in mice injected with anti-Fas
mAb (Fig. 3A), but not in control IgG-treated mice (Fig. 3B).
Mesangial cell damage was incipient at three hours after anti-Fas
injection, and its severity increased with time (Table 2). At 24
hours glomerular injury was clearly established and consisted of
depletion of mesangial cells, which led to an apparent increase of
mesangial matrix (Fig. 3A). Capillary thrombosis was not present.
As Fas activation results in apoptosis of cultured mesangial cells,
we searched for evidence of apoptosis in the glomeruli from
anti-Fas mAb-injected mice. Fragmented and pyknotic nuclei
could be observed in the mesangium of anti-Fas mAb-injected
mice by optical microscopy (Fig. 3A) and by fluorescence micros-
copy of propidium iodide-stained sections (Fig. 4A). DNA frag-
mentation was detected in situ by the TUNEL technique in
mesangial cells with characteristic apoptotic morphology (Fig.
4B). Quantitation of glomerular apoptotic cells revealed approx-
imately a fivefold increase in the rate of apoptosis three hours
after anti-Fas injection. The number of apoptotic glomerular cells
peaked at 24 hours (anti-Fas injected 36 9, IgG-injected 0.9
0.7 apoptotic cells per 20 glomerular cross sections, P < 0.0002
Fig. 5). Internucleosomal DNA fragmentation was present in
kidneys from anti-Fas mAb-injected mice but not from controls
injected with IgG (Fig. 4C). Occasional apoptotic tubular cells
were observed.
Decomplemented mice also developed proteinuria, hematuria
and the glomerular lesions (Tables 1 and 2, and Fig. 3C).
Glomerular apoptotic cells were also noted (33 4 apoptotic cells
per 20 glomerular cross sections). Neither C3 nor neutrophil
infiltration were found in the glomeruli of anti-Fas mAb-injected
mice.
Injection of anti-Fas mAb also induced liver injury that con-
sisted of apoptosis of hepatocytes [19J(Table II). Liver injury was
present in both complement-sufficient and complement-depleted
mice.
Discussion
Recent reports have emphasized a role for apoptosis in the
pathogenesis of glomerular injury [1]. However, there is little
information on the factors that promote glomerular cell apoptosis
in vivo. Cultured human mesangial cells are sensitive to Fas-
induced death [31j and Fas is a candidate mediator of mesangial
cell apoptosis in vivo. In this paper we have shown that agonistic
anti-Fas antibodies induce apoptosis of cultured murine mesan-
gial cells. Furthermore, injection of agonistic anti-Fas antibodies
to mice causes proteinuria, hematuria and mesangial cell deple-
tion within 24 hours. Morphological and functional studies indi-
cated that apoptosis was the mode of glomerular cell loss.
Identification of the precise lineage of apoptotic cells is not always
possible [4fl. The association between the amount of glomerular
cell apoptosis and the presence of acellular mesangial matrix
suggests that mesangial cells underwent apoptosis. Other glomer-
ular cells could also be targets of anti-Fas antibodies. However,
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Fig. 2. Agonistic anti-Fas antibodies induce
apoptosis of cultured mesangial cells. A and B.
Murine mesangial cells were cultured in glass
slides in the presence of 10 j.g/ml control
hamster IgG or Jo2 anti-murine Fas mAb for
24 hours. Cells were then formalin-fixed and
stained with propidium iodide. Decreased cdl
numbcr and the presence of pyknotic, dense
and fragmented apoptotic nuclei were noted
among cells treated with anti-Fas mAb. The
arrow points Out one of several apoptotic nuclei
(A). No such nuclei are observed in cells
cultured with control IgU (B). (C) Electron
microscopy of Fas-induced apoptosis. Note the
condensed, marginated chromatin. (D) Flow
cytometry analysis of DNA content of
permeabilizcd, propidium iodide-stained cells.
A distinct A0 peak of subdiploid DNA content
is observed among cells treated with anti-Fas
mAb (Fas), but is absent in IgG-treated cells
(IgG). (E) Internucleosomal degradation was
noted in low molecular weight DNA obtained
from cells treated with anti-Fas mAb (Fas), but
not in cells treated with control IgG or control
media (C).
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Fig. 3. Agonist/c anil-Fas antibodies induce ,nesangial cell ijwy in mice.
(A) Kidney obtained from a mouse 24 hours after the injection of IC q
anti-Fas mAb. Note the glomerular areas of mesangial ccli depletion. Attç.% '1 17 kidney (i-i&E, X25t)). (C) Kidney obtained from a decomplementetfragmented nucleus is present (arrow) (H&E stain, X250). (B) Contro
mouse 10 hours after the injection of 10 p.g anti-Fas mAh. Nott
•6
apoptotic cells with marginated chromatin (arrow) (H&E X500).
incipient areas of mesangial cell depletion and the presence 0!
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Table 1. Anti-Fas Ab induce proteinuria and hematuria in mice
Group Basal
0.9%
NaCI lgG/Dec IgG Fas Fas Fas Fas Fas/Dec
time hours 0 24 10 24 3 6 10 24 10
+ + + + + +I++ ++I+++ +++ ++
—/++ +/++ +++ ++
37 2 3 3 3 3 3 6 3
Proteinuria and hematuria were assessed by dipstick before injections (Basal) or immediately before sacrifice in animals injected with vehicle (0.9%
NaCI), 10 pg control IgG (IgG) or 10 pg anti-Fas mAb (Fas). Proteinuria scores are: (—) negative, (+) 30 mgldl, (++) 100 mgldl, (+++) 500 mg/dl.
Hematuria scores are: (—) negative, (+) 10 erythrocytes/pJ, (+ +) 50 ery/rl, (+ + +) 250 ery/jJ. Three mice injected with anti-Fas mAb died before urine
could be evaluated. Post-injection urine samples were not available for mice sacrificed 0.5 hr (N = 2) and 1 hr (N = 2) after anti-Fas administration.
Four mice were used as non-injected controls. Abbreviation Dec is decomplemented.
Fig. 3. Agonistic anti-Fas antibodies induce mesangial cell injuly i  i .
( i  f  ouse 24 hours after the injection of 10 pg
anti-   Note the glo erular areas of mesangial cell depletion. A
fr g ented nucleus is present (arrow) (H&  stain, ).  ontrol
ki ey (H 0  f  ecomplemented
se 10 hours after the i j t    ti  b te
i i   de letion and the presence of
apoptotic cells with arginated chromatin (arrow) (H& , .
there is no information regarding the ability of glomerular endo-
thelial and epithelial cells to express Fas.
It has previously been reported that agonistic anti-Fas mAb
induced a complement-independent, apoptotie injury of hepato-
cytes in mice, but the glomerular injury was overlooked [19].
These authors performed their histological studies at two hours.
In our experience glomerular damage became fully established at
later time points. The lower dose of anti-Fas antibody used in our
study decreased the severity of the liver injury and improved
mouse survival. In our model the time course of liver and
glomerular apoptosis was similar. Both were already noted at
three hours, and peaked between 10 and 24 hours. Taken together
with the facts that cultured mesangial cells express Fas and
undergo apoptosis upon Fas activation and that Fas mRNA is
found in normal mouse glomeruli, the in vivo data suggest that
glomerular injury is caused by the agonistic anti-Fas antibodies,
and is not secondary to liver damage. Indeed, the renal injury
observed in experimental models and clinical acute liver damage
is acute tubular necrosis [42]. Tubular injury in our model was
inconspicuous, and only a few, scattered, apoptotic tubular cells
were observed. When glomerular abnormalities develop in liver
disease they are late events and optical and electron microscopical
assessment of glomeruli remain normal for days after the induc-
tion of severe acute liver injury [43].
There is no satisfactory model of mesangial cell injury in mice.
Anti-Thy-i antibodies recognize a cell membrane antigen in rat
Proteinuria
Hematuria
N
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Table 2. Liver and kidney pathology
Group Control
0.9%
NaCI IgG/Dec IgG Fas Fas Fas Fas Fas/Dec
time hours 24 24 10 24 3 6 10 24 10
Liver
apoptosis — — —7+ +/+++ ++/+++ ++/+++ +++
Mesangial
apoptosis — —7+ + +/++ +/++ ++
Mesangiolysis — — — — — —/++ + +/++ ++
N 4 2 3 3 3 3 3 6 3
Tissue sections from non-injected mice (control) and mice injected with vehicle (0.9% NaCl), 10 pg control lgG (lgG) or 10 pg anti-Fas mAb (Fas)
were evaluated. Cells were considered apoptotic when nuclei were pyknotic and fragmented. Liver cell apoptosis scores are: 0, absence; 1+, <25%
apoptotic cells; 2+, 25-50% apoptotic cells; 3+, >50% apoptotic cells. Mesangial cell apoptosis scores are: 0, absence; 1+, apoptotic cells in <50% of
glomeruli; 2+, apoptotic cells present in >50% of glomeruli. Mesangiolysis was defined as the presence of acellular mesangial matrix. It was scored as:
0, absence; 1+, mild; 2+, severe. Dec denotes decomplemented mice.
M IgG Fas
Fig. 4. Mesangial cell injury induced by Fas activation has features of
apoptosis. (A) A propidium iodide stained glomerulus from a mouse
injcctcd 24 hours earlier with 10 pg anti-Fas mAb. Note accllular areas
and the pyknotic and fragmented nuclei marked by arrows (X500). (B)
In situ detection of DNA fragmentation by terminal deoxynucleotidc
transfcrasc staining. A stained cell with pyknotic nucleus can he
observed. The sample was obtained six hours after anti-Fas mAb
injection (X250). (C) Internucleosomal DNA degradation is present in
kidneys from mice injected with anti-Fas mAb 24 hours earlier (Fas).
Abbreviations are: IgO, control TgG-injected; M, molecular weight
markers.
mesangial cells. In rats the administration of anti-Thy-I Ab results
in complement-dependent acute mesangiolysis that is associated
with glomerular C3 deposition and neutrophil infiltration [36, 44,
45]. Mesangial damage is prevented by decomplementation with
cobra venom factor [36, 45]. However, anti-Fas mAb-induced
glomerular injury in mice does not appear to depend on comple-
ment activation. Decomplemented mice also developed protein-
uria, hematuria and the glomerular lesions. Neither C3 nor
neutrophil infiltration were found in the glomeruli of anti-Fas
mAb-injected mice. In preliminary studies we did not detect
evidence of glomerular hypcrcellularity, a key feature of comple-
ment-mediated mesangial cell injury [61, in anti-Fas mAb-injected
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Fig. 5. .4gonistic anti-Fas antibodies induce glomerular cell apoptosis in
vivo. The number of apoptotic cells per 20 glomerular cross sections was
quantitated in oil-immersion light microscopy of PAS-stained sections.
*p < 0.0002 versus Control IgG at 24 hours.
cultured renal cells [12, 40].
In conclusion, although the precise role of Fas in glomerulone-
phritis remains to be established, our study suggests that activa-
tion of the Fas receptor may play a causative role in experimental
glomcrular injury as agonistic anti-Fas mAb induces mesangial
cell death in vitro and in vivo. This may also be the case in human
glomerular diseases characterized by T lymphocyte infiltration, as
Fas activation induces apoptosis of cultured human mesangial
cells [31]. The availability of recombinant Fas ligand will help
confirm our findings as direct injection of this cytokinc into the
renal artery of other experimental animals will provide a more
convenient model of Fas-induced renal injury. Fas antagonism
should be explored in the therapy of glomerulonephritis.
Acknowledgments
This work was supported, in part, by grants from Fundación Renal Inigo
Alvarez de Toledo, FISS (92/5277, 93/5389, 94/0370), Ministerio de
Educación y Cicncia (PB 94/0211 and 95/0093), CICYT (SAF 97/0071),
and the EEC project CT 92-1332. S.G.C. was supported by the Fundación
Conch ita Rabago, and C.L. by the Universidad Autónoma de Madrid and
Ministerio de EducaciOn y Ciencia.
Reprint requests to Alberto Ortiz, M.D., Laboratorio de Nefrologla,
Fundación Jiménez DIaz, Avda Reyes Católicos 2, 28040 Madrid, Spain.
E-mail: aarduan@lander.es
References
1. SAVILL J: Apoptosis and the kidney. JAm Soc Nephrol 5:12—21, 1994
2. THOMPSON CB: Apoptosis in the pathogenesis and treatment of
disease. Science 267:1456—1462, 1995
3. STRUTZ F, OKADA H, Lo CW, DANOFF TD, CARONE RL, TOMASZE-
wSKI JE, NEILSON EG: Identification and characterization of a new
fibroblast specific marker: FSP-1. J Cell Biol 130:393—406, 1995
4. FLOEGE J, TOPLEY N, HOPPE J, BARRETT TB, RESCH K: Mitogenic
effect of platelet-derived growth factor in human glomerular mesan-
gial cells: Modulation and/or suppression by inflammatory cytokines.
C/in Exp Immunol 86:334—341, 1991
5. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BARRETT TB, BOWEN-
POPPE DF, JOHNSON RJ: Infusion of platelet-derived growth factor or
basic fibroblast growth factor induces selective glomerutar mesangial
cell proliferation and matrix accumulation. J C/in Invest 92:2952—2062,
1993
6. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL
J: Mesangial cell apoptosis: The major mechanism for resolution of
glomerular hypercellularity in experimental mesangial proliferative
nephritis. J C/in Invest 94:2105—2116, 1994
7. MOONEY A, SAVILL J: Insulin-like growth factor-i (IGF-1) is a
candidate mesangial cell survival factor, inhibiting MC apoptosis in
vitro. (abstract) JAm Soc Nephrol 6:877, 1994
8. CLEVELANO JL, IHLE JN: Contenders in FasL/TNF death signalling.
Cell 81:479—482, 1995
9. MARTIN SJ, GREEN DR: Protease activation during apoptosis: Death
by a thousand cuts? Cell 82:349—352, 1995
10. STELLER H: Mechanisms and genes of cellular suicide. Science 267:
1445-1449, 1995
11. ORTIZ A, BusTos C, ALONSO J, ALCAZAR R, LOPEZ-ARMADA MJ,
PLAZA JJ, GONZALEZ E, EGI00 J: Involvement of tumor necrosis
factor alfa in the pathogenesis of experimental and human glomeru-
lonephritis. Adv Nephrol 24:53—78, 1995
12. SUDA T, TAKAHASIII T, GOLSTEIN P, NAGATA S: Molecular cloning
and expression of the Fas ligand, a novel member of the tumor
necrosis factor family. Cell 75:1169—1178, 1993
13. TAKAIIASHI T, TANAK M, BRANNAN CI, JENKINS NA, COPELANO NG,
SUDA T, NAGATA S: Generalized lymphoproliferative disease in mice,
caused by a point mutation in the Fas ligand. Cell 76:969—976, 1994
14. KAGI D, VIGNAOUX F, LEDERMANN B, BURKI K, DEPRAETERE V,
NAGATA S, HENGARTNER H, GOLSTEIN P: Fas and perform pathways
as major mechanisms of T cell-mediated cytotoxicity. Science 265:528—
530, 1994
15. SMITH CA, FARRAH T, GoODwIN RG: The TNF receptor superfamily
of cellular and viral proteins: Activation, costimulation, and cell death.
Cell 76:959—962, 1994
16. ITOH N, YONEHARA S, ISHII A, YONEHARA M, MIZUSHIMA S, SA-
MASHIMA M, HASE A, SET0 Y, NAGATA S: The polypeptide encoded
by the eDNA for human cell surface antigen Fas can mediate
apoptosis. Cell 66:233—243, 1991
17. TRAUTH BC, KLAS C, PETERS AMJ, MATZUKU 5, MOIIER P, FALK W,
DEBATIN KM, KRAMMER PH: Monoclonal antibody-mediated tumor
regression by induction of apoptosis. Science 245:301—305, 1989
18. YONEHARA S, ISHI A, YONEHARA M: A cell-killing monoclonal
antibody (anti-Fas) to a cell surface antigen co-down regulated with
the receptor of TNF. J Exp Med 169:1747—1756, 1989
19. OGASAWARA J, WATANABE-FUKUNAGA K, ADACHI M, MATSUZAwA A,
KASUGAI T, KFFAMURA Y, ITOH N, SUOA T, NAGATA S: Lethal effect
of the anti-Fas antibody in mice. Nature 364:806—809, 1993
20. MIYAWAKI T, UEHARA T, NIBU R, TSUJI T, YACHIE A, YONEHARA 5,
TANIGUCHI N: Differential expression of apoptosis-related Fas antigen
on lymphocyte suhpopulations in human peripheral blood. J Immunol
149:3753—3758, 1992
60
50
0
0
0)
30
.0
.2 20
a0
10
I
mice followed for one to two weeks. This further supports the
notion that the pathogenesis of mesangial cell injury induced by
Fas activation differs from complement-mediated lysis.
The precise role of Fas in glomerular injury remains to be
established. Our data establish the susceptibility to Fas-induced
apoptosis of glomerular cells, but they do not provide insights into
the significance of this susceptibility in normal development and
the pathogenesis of glomerular disease. We speculate that death
of mesangial cells induced by Fas may participate in mesangial cell
loss in the early stages of glomerular injury, in the repair phase of
glomerular hypercellularity and in the chronic glomerular cell
depletion that characterizes glomerular sclerosis. T cells may be
sources of Fas ligand [12—14]. Infiltrating T cells are present in
damaged glomeruli and they have the capacity to kill renal cells
and induce renal damage [29, 46]. In addition, expression of fas
ligand mRNA has also been detected in the normal kidney and
1746 Gonzdlez-Cuadrado et al: Fas and glomemlar injuly
21. CHINNAIYAN AM, O'ROURKE K, TEWARI M, DIxIT VM: FADD, a
novel death domain-containing protein, interacts with the death
domain of Fas and initiates apoptosis. Cell 81:505—512, 1995
22. KUIDA K, LIPPKE JA, Ku G, HARDING MW, LIVINGSTON DJ, Su MSS,
FLAVELL RA: Altered cytokine export and apoptosis in mice deficient
in interleukin-113 converting enzyme. Science 267:2000—2003, 1995
23. JAATTELA M, BENEDICT M,TEWARI M, SHAYMAN JA, DIxIT VM: Bcl-x
and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of
phospholipase A2 in breast carcinoma cells. Oncogene 10:2297—305,
1995
24. BoIsE LH, MINN AJ, NOEL PJ, JUNE CH, ACCAVITrI MA, LINDSTEN T,
THOMPSON CB: CD28 costimulation can promote T cell survival by
enhancing the expression of Bcl-XL. Immunity 3:87—98, 1995
25. MAPARA MY, BARGOU R, ZUGEK C, DOHMER H, USTAOGLA F,
JONKER RR, KRAMMER PH, DORKEN B: APO-1 mediated apoptosis or
proliferation in human chronic B lymphocytic leukemia: Correlation
with bcl-2 oncogene expression. Eur J Immunol 23:702—708, 1993
26. TAKAYAMA S, SATO T, KRAJEWSKI S, KOCHEL K, IRIE S, MILLAN JA,
REED JC: Cloning and functional analysis of BAG-i: A novel Bc12
binding protein with anti-cell death activity. Cell 80:279—284, 1995
27. SATO T, IRIE S, KITADA S, REED JC: FAP-1: A protein tyrosine
phosphatase that associates with Fas. Science 268:411—414, 1995
28. CHENG J, Zou T, LIU C, SHAPIRO JP, BRAUER MJ, KIEFER MC,
BARR PJ, MOUNTZ JD: Protection from Fas-mediated apoptosis by a
soluble form of the Fas molecule. Science 263:1759—1762, 1994
29. ORTIZ A, ALONSO J, GOMEZ-CHIARRI M, LERMA JL, SERON D,
CONDOM E, GONZALEZ E, EGIDO J: Fibronectin decreases glomerular
lesions and synthesis of TNF, PAF and fibronectin in proliferative
glomerulonephritis. Clin Exp Immunol 101:334—340, 1995
30. SHIMIZU A, KITAMURA H, MASUDA Y, ISHIZAKI M, SUGISAKI Y,
YAMANAKA N: Apoptosis in the repair process of experimental
proliferative glomerulonephritis. Kidney mt 47:114—121, 1995
31. GONZALEZ-CUADRADO S, LOPEZ-ARMADA MJ, GOMEZ-GUERRERO C,
SUBIRA D, GARCIA-SAHUQUILLO A, ORTIZ-GONZALEZ A, NEILSON
EG, EGID0 J, ORTIZ A: Anti-Fas antibodies induce cytolysis and
apoptosis in cultured human mesangial cells. Kidney mt 49:1064—1070,
1996
32. WOLF G, HABERSTROH U, NEILSON EG: Angiotensin II stimulates the
proliferation and biosynthesis of type I collagen in cultured murine
mesangial cells. Am JPathol 140:95—107, 1992
33. EGIDO J, ROBLES A, ORTIZ A, RAMIREZ F, GONZALEZ E, MAMPASO F,
SANCHEZ CRESPO M, BRAQUET F, HERNANDO L: Role of platelet
activating factor in Adriamycin-induced nephropathy in rats. Eur
JPharmacol 138:119—123, 1987
34. SYLVESTRE DL, RAVETCH JV: Fe receptors initiate the Arthus reac-
tion: Redefining the inflammatory cascade. Science 265:1095—1098,
1994
35. COCHRANE CG, MULLER-EBERHARD HJ, AIKIN BS: Depletion of
plasma complement in vivo by a protein of cobra venom: Its effect on
various immunologic reactions. J Immunol 105:55—69, 1970
36. YAMAMOTO T, WILSON CB: Complement dependence of antibody-
induced mesangial cell injury in the rat. J Immunol 138:3758—3765,
1987
37. GOMEZ-CHIARRI M, ORTIZ A, GONZALEZ-CUADRADO 5, SERON D,
EMANCIPATOR SN, HAMILTON TA, BARAT A, PLAZA JJ, GONZALEZ F,
EGIDO J: Interferon-inducible protein 10 (IP-i0) is highly expressed in
rats with experimental nephrosis. Am J Pathol 148:301—31l, 1996
38. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by
acid guanidinium thiocyanate-phenol-chloroform extraction. Anal
Biochem 162:156—159, 1987
39. WATANABE-FUKUNAGA R, BRANNAN CI, ITOH N, YONEIIARA S, COPE-
LAND NG, JENKINS NA, NAGATA 5: The eDNA structure, expression,
and chromosomal assigment of the mouse fas antigen. J Immunol
148:1274—1279, 1992
40. ORTIZ-ARDUAN A, DANOFF TM, KALLURI R, GONZALEZ-CUADRADO
S, KARP SL, ELKON K, EGIDO J, NEILSON EG: Regulation ofFas, Fas
ligand expression in cultured murine renal cells and in the kidney
during endotoxemia. Am J Physiol (in press)
41. ARENDS MJ, WYLLIE AH: Apoptosis: Mechanisms and roles in
pathology. mt Rev Exp Pathol 32:223—254, 1991
42. SOLEZ K, RACUSEN LC, JEWELL LD: Pathology of acute renal failure
occurring in liver disease, in The Kidney in Liver Disease, edited by
EPSTEIN M, Baltimore, Williams & Wilkins, 1998, pp 182—206
43. OGATA 1, FUJIWARA K, NI5HI T, KUWATA 5, OHTA Y,N0SAKA K, Oi
H: Contribution of hepatic reticuloendothelial system to glomerular
IgA deposition in rat liver injury. Am J Pathol 131:411—417, 1988
44. BAGCHUS WM, HOEDEMAEKER PJ, R0zING J, BAKKER WW: Glomer-
ulonephritis induced by monoclonal anti-Thy 1.1. antibodies. A se-
quential histological and ultrastructural study in the rat. Lab Invest
55:680—687, 1986
45. JoHNsoN RJ, IIDA H, PRITZL P, ALPERS CE: Platelet-complement
interactions in mesangial proliferative nephritis in the rat. Am J Pathol
138:313—322, 1990
46. WEISS RA, MADAIO MP, TOMASZEWSKI JE, KELLY CJ: T cells reactive
to an inducible heat shock protein induce disease in toxin-induced
interstitial nephritis. J Exp Med 180:2239—2250, 1994
